You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Carbamazepine for schizophrenia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, May 2014
|
| DOI | 10.1002/14651858.cd001258.pub3 |
| Pubmed ID | |
| Authors |
Stefan Leucht, Bartosz Helfer, Markus Dold, Werner Kissling, John McGrath |
| Abstract |
Many people with schizophrenia do not achieve a satisfactory treatment response with just antipsychotic drug treatment and various adjunct medications are used to promote additional response. The antiepileptic carbamazepine is one such drug. |
X Demographics
The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 17% |
| India | 1 | 6% |
| Cuba | 1 | 6% |
| Spain | 1 | 6% |
| United States | 1 | 6% |
| Unknown | 11 | 61% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 72% |
| Practitioners (doctors, other healthcare professionals) | 3 | 17% |
| Science communicators (journalists, bloggers, editors) | 1 | 6% |
| Scientists | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 258 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Denmark | 1 | <1% |
| Unknown | 257 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 40 | 16% |
| Student > Bachelor | 35 | 14% |
| Researcher | 26 | 10% |
| Student > Ph. D. Student | 22 | 9% |
| Student > Doctoral Student | 18 | 7% |
| Other | 46 | 18% |
| Unknown | 71 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 76 | 29% |
| Psychology | 33 | 13% |
| Nursing and Health Professions | 26 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 4% |
| Agricultural and Biological Sciences | 6 | 2% |
| Other | 26 | 10% |
| Unknown | 81 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2024.
All research outputs
#3,084,159
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#5,833
of 13,156 outputs
Outputs of similar age
#29,698
of 242,620 outputs
Outputs of similar age from Cochrane database of systematic reviews
#102
of 218 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,620 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 218 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.